سعر ايديكوين 400 مجم 5 اقراص 2022

• In 2008 the US FDA determined that all TEQUIN (gatifloxacin) products, including 400 mg oral tablets, were withdrawn from sale for reasons of safety; they were removed from the Orange Book and FDA will not approve generic versions referring to them.International label, same formulation · Federal Register (U.S. Food and Drug Administration notice)
• The petition considered by FDA cited an increased risk of dysglycaemia (hypoglycaemia and hyperglycaemia) with gatifloxacin, including a 2006 study reporting about 17-fold odds of hyperglycaemia and 4-fold odds of hypoglycaemia versus macrolide antibiotics in diabetic and non-diabetic patients.General active-ingredient information · Federal Register (U.S. Food and Drug Administration notice)

• Given the documented dysglycaemia signal, blood glucose disturbances are the key safety concern for systemic gatifloxacin (no current official label with monitoring instructions was found).General active-ingredient information · Federal Register (U.S. Food and Drug Administration notice)

English text not available for this section.